Catalyst Wire Dossier Catalyst Wire Dossier

YM150

· Astellas Pharma Inc.
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for YM150, covering 2010-05-06 to 2015-10-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery [Phase 2, Phase 3]

See pricing